Decoy Therapeutics Inc.
DCOY
Rank in Stocks
#33363
Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage... Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.
Share Price
$1.06
Last synced: 2026-11-12
Market Cap
$561.23K
Change (1 day)
-3.21%
Change (1 year)
-92.73%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Decoy Therapeutics Inc. (DCOY)
Category
Healthcare
EPS for Decoy Therapeutics Inc. (DCOY)
EPS as of June 2026 TTM: $-29.09
According to Decoy Therapeutics Inc.'s latest financial reports, its current EPS (TTM) is $-29.09. At the end of 2025 the company had an EPS of $-25.99, an increase over its 2024 EPS of $-86.92.
EPS history for Decoy Therapeutics Inc. from 2014 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-29.09 | 11.93% |
| 2025 | $-25.99 | -70.10% |
| 2024 | $-86.92 | -81.15% |
| 2023 | $-461.04 | -74.18% |
| 2022 | $-1.79K | 92.80% |
| 2021 | $-926.01 | -34.60% |
| 2020 | $-1.42K | -77.76% |
| 2019 | $-6.37K | -92.71% |
| 2018 | $-87.37K | -41.46% |
| 2017 | $-149.25K | -18.11% |
| 2016 | $-182.25K | 16.83% |
| 2015 | $-156.00K | -54.49% |
| 2014 | $-342.75K | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -153.83% |
US
|
|
| $-7.07 | -75.70% |
US
|
|
| $-5.29 | -81.82% |
AU
|
|
| $12.88 | -144.28% |
BE
|
|
| $21.56 | -174.11% |
NL
|
Questions about Decoy Therapeutics Inc.'s earnings per share (EPS)
What is Decoy Therapeutics Inc.'s earnings per share (EPS)?
Decoy Therapeutics Inc.'s earnings per share (EPS) over the last twelve months is $-29.09, as of Jun 2026.
What was Decoy Therapeutics Inc.'s earnings per share (EPS) in 2025?
In 2025, Decoy Therapeutics Inc.'s earnings per share (EPS) was $-25.99, compared with $-86.92 in 2024.
How has Decoy Therapeutics Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Decoy Therapeutics Inc.'s earnings per share (EPS) was highest in 2025 ($-25.99) and lowest in 2022 ($-1.79K).
How does Decoy Therapeutics Inc.'s earnings per share (EPS) compare with similar companies?
Decoy Therapeutics Inc.'s earnings per share (EPS) ($-29.09) is lower than that of all 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.